Amber Zavala

6505--Fluorouracil RFP

The Department of Veterans Affairs, through its National Acquisition Center, is soliciting bids for Fluorouracil 5% Cream under solicitation number 36E79726R0024, titled 6505--Fluorouracil RFP, in accordance with FAR Part 12 as a commercial item procurement. This unrestricted contract aims to secure an uninterrupted supply of 126,107 tubes of Fluorouracil 5% Cream, each containing 40 grams, for distribution to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service through their respective Pharmaceutical Prime Vendor Programs. The contract term includes one base year and four pre-priced one-year option periods, with the requirement that all drug products must bear a unique NDC number and be labeled exactly as the name appears on the official product label. Glass packaging is strictly prohibited, and offerors must ensure compliance with these specifications to be considered. Proposals must be submitted electronically via SAM.gov by the deadline of June 22, 2026, at 2:30 p.m. Central Time, with no paper copies available or accepted. The award will be made to the responsible offeror capable of guaranteeing continuous, reliable supply, with no set-asides or preference programs applied. All inquiries should be directed to Contract Specialist Amber Zavala at [email hidden] or [phone hidden], located at the VA office in Hines, Illinois, 60141. Offerors are advised to monitor the SAM.gov portal continuously for any amendments or updates to the solicitation.

Department Of Veterans AffairsIL,

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

Posted Jun 26, 2026

unrestricted36E79726R0024

Closed

Awarded5

6505--Buprenorphine Award

The Department of Veterans Affairs, through its National Acquisition Center, issued solicitation 36E79726R0004 for the supply of Buprenorphine HCL/Naloxone HCL sublingual tablets in two dosage forms—2 mg/0.5 mg and 8 mg/2 mg—each in 30-count bottles. The procurement follows FAR Part 12 commercial item procedures under NAICS code 325412 and is structured as a multi-year contract with a one-year base period and four one-year option periods, allowing for an aggregate performance window of up to five years. Offerors must comply with stringent packaging and labeling standards, including the use of non-glass containers with deshellable or convertible safety caps, minimum 120cc bottle capacity, 5.25” x 2” label dimensions, and mandatory GS1-compliant barcodes encoding the 11-digit NDC number on both immediate and outer containers. Barcodes must meet ANSI/ISO/IEC Grade C or higher quality standards and be placed to ensure scannability under normal use, with human-readable data adjacent to the barcode for VA’s BCMA systems. All products must conform to FDA cGMP regulations, USP-NF standards, and DSCSA requirements, with offerors required to certify successful stability testing across all proposed package sizes. The solicitation includes multiple FAR clauses related to small business set-asides, including 52.219-6, 52.219-7, and 52.219-27, indicating potential set-asides for small businesses, service-disabled veteran-owned small businesses, and other socioeconomically disadvantaged concerns. Subcontracting plans are required under 52.219-9, with model outlines provided, and the nonmanufacturer rule applies to ensure compliance with small business participation. Proposal submissions must be sent via email to designated VA addresses in Word or PDF format, with no zip files or faxes permitted, and must include a completed SF-1449 form, UEI and CAGE codes, NDC information, and all required certifications. The award will be made using a Lowest Priced Technically Acceptable (LPTA) methodology, evaluating technical acceptability, past performance, and cost, with the lowest-priced acceptable offer selected. The due date for offers was extended twice, from January 20, 202

Department Of Veterans AffairsIL, USA$21M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

Unrestricted

Awarded

Federal4

6505--Metolazone Tablets (VA-26-00032237)

The Department of Veterans Affairs National Acquisition Center plans to issue a Request for Proposal (RFP) for the procurement of Metolazone Tablets to serve the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. This contract will be awarded to a single responsible offeror who can guarantee a continuous supply of the medication. The base contract period is one year, with four additional one-year option periods at pre-established prices. Distribution will occur through the Pharmaceutical Prime Vendor Programs of the VA and DOD. Offerors must provide the exact product name as labeled, along with a unique NDC number, and packaging in glass bottles is prohibited. The solicitation will be released electronically around April 1, 2026, with a closing date around April 14, 2026, and all related documents will be accessible exclusively via the official federal procurement website. The estimated annual demand for Metolazone Tablets includes 700 bottles of 10 mg size, 7,649 bottles of 2.5 mg size, and 6,614 bottles of 5 mg size, each packaged in bottles of 100 tablets. The solicitation follows commercial item procurement procedures under FAR Part 12 and is classified under NAICS code 325412. Interested parties are encouraged to monitor the procurement site regularly for updates and amendments. The designated point of contact for inquiries is Amber Zavala, who can be reached by email or phone for additional information. This effort aims to ensure a reliable supply of this essential medication across multiple federal healthcare programs.

Department Of Veterans AffairsIL,

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

Posted Apr 22, 2026

small business36E79726R0016

Closed

Awarded4

6505--Hydralazine HCL Tablets Effective 04/08/2026 to 04/07/2027

The Department of Veterans Affairs National Acquisition Center awarded contract 36E79726D0013 to Radha Pharmaceuticals Inc. for the supply of Hydralazine HCL Tablets. The award, valued at 7,450,452.60 dollars, covers a performance period from April 8, 2026, to April 7, 2027. This procurement was conducted as an unrestricted, firm-fixed-price, indefinite-delivery requirements contract under NAICS code 325412. The contract provides pharmaceuticals for the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service, with distribution managed through Pharmaceutical Prime Vendor Programs. The scope of the award includes seven line items for Hydralazine HCL tablets in various strengths (10mg, 25mg, 50mg, and 100mg) and bottle sizes (100 and 1000 count). The contract structure consists of a one-year base period with four optional one-year extensions. Technical requirements mandate strict adherence to FDA cGMP compliance, the use of unique 11-digit National Drug Codes, and specific packaging standards that prohibit glass bottles and require child-resistant caps for smaller containers. Administration of the contract involves a non-standard payment flow where the contractor is paid by Pharmaceutical Prime Vendor contractors, such as McKesson Corporation and Cencora, rather than directly by the government. Consequently, the contractor is prohibited from invoicing government facilities and must maintain binding business-to-business agreements with the designated prime vendors. Award was based on the Lowest Price Technically Acceptable (LPTA) evaluation method, ensuring all technical and FDA regulatory thresholds were met before price became the deciding factor.

Department Of Veterans AffairsIL, USA$7.5M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

unrestricted

Awarded

Federal2